Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia

التفاصيل البيبلوغرافية
العنوان:	Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
المؤلفون:	Chandrakala, S., Toshniwal, Manoj, Halvawala, Mitesh, Padwal, Namita, Sidharthan, Neeraj, Malhotra, Pankaj, Prashantha, B., Ballikar, Riya, Shah, Sandip, Apte, Shashikant, Viswanathan, T. Kasi, Ramanan, Vijay, Sharma, Akhilesh, Pawar, Dattatray, Pawar, Roshan^{Aff13, IDs12288022016025_cor15}, Shahavi, Vinayaka
المصدر:	Indian Journal of Hematology and Blood Transfusion. :1-7
قاعدة البيانات:	Springer Nature Journals

كن أول من يترك تعليقا!